Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

被引：2
|
作者：
Ilona Joniec-Maciejak
Adriana Wawer
Danuta Turzyńska
Alicja Sobolewska
Piotr Maciejak
Janusz Szyndler
Dagmara Mirowska-Guzel
Adam Płaźnik
机构：
[1] Medical University of Warsaw,Department of Experimental and Clinical Pharmacology
[2] Centre for Preclinical Research and Technology (CePT),Department of Neurochemistry
[3] Institute of Psychiatry and Neurology,undefined
来源：
Pharmacological Reports | 2018年 / 70卷
关键词：
Parkinson’s disease; Octanoic acid; MPTP; PGC-1α; PEPCK;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：988 / 992
页数：4
相关论文
共 50 条
  • [31] Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease
    Martin, Heather L.
    Santoro, Matteo
    Mustafa, Sarah
    Riedel, Gernot
    Forrester, John V.
    Teismann, Peter
    GLIA, 2016, 64 (03) : 386 - 395
  • [32] MPTP as a mitochondrial neurotoxic model of Parkinson's disease
    Przedborski, S
    Tieu, K
    Perier, C
    Vila, M
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2004, 36 (04) : 375 - 379
  • [33] Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease
    Pasquarelli, Noemi
    Porazik, Christoph
    Bayer, Hanna
    Buck, Eva
    Schildknecht, Stefan
    Weydt, Patrick
    Witting, Anke
    Ferger, Boris
    NEUROCHEMISTRY INTERNATIONAL, 2017, 110 : 14 - 24
  • [34] Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia
    Silverdale, MA
    Crossman, AR
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 2002, 174 (01) : 21 - 28
  • [35] Characterization of the Striatal Extracellular Matrix in a Mouse Model of Parkinson's Disease
    Freitas, Ana
    Aroso, Miguel
    Barros, Antonio
    Fernandez, Miriam
    Conde-Sousa, Eduardo
    Leite, Marina
    Carvalho, Eva Daniela
    Ribeiro, Cristina C.
    Ferreira, Rita
    Pego, Ana Paula
    Vitorino, Rui
    Gomez-Lazaro, Maria
    ANTIOXIDANTS, 2021, 10 (07)
  • [36] L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease
    King, Jennifer M.
    Muthian, Gladson
    Mackey, Veronica
    Smith, Marquitta
    Charlton, Clivel
    LIFE SCIENCES, 2011, 89 (17-18) : 638 - 643
  • [37] PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease
    Yun, Hyung-Mun
    Choi, Dong Young
    Oh, Ki Wan
    Hong, Jin Tae
    MOLECULAR NEUROBIOLOGY, 2015, 52 (01) : 422 - 431
  • [38] A Disruption Mechanism of the Molecular Clock in a MPTP Mouse Model of Parkinson’s Disease
    Akane Hayashi
    Naoya Matsunaga
    Hiroyuki Okazaki
    Keisuke Kakimoto
    Yoshinori Kimura
    Hiroki Azuma
    Eriko Ikeda
    Takeshi Shiba
    Mayumi Yamato
    Ken-ichi Yamada
    Satoru Koyanagi
    Shigehiro Ohdo
    NeuroMolecular Medicine, 2013, 15 : 238 - 251
  • [39] Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease
    Wang, Li-Yuan
    Yu, Xin
    Li, Xiao-Xi
    Zhao, Yi-Nan
    Wang, Chun-Yan
    Wang, Zhan-You
    He, Zhi-Yi
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [40] A Disruption Mechanism of the Molecular Clock in a MPTP Mouse Model of Parkinson's Disease
    Hayashi, Akane
    Matsunaga, Naoya
    Okazaki, Hiroyuki
    Kakimoto, Keisuke
    Kimura, Yoshinori
    Azuma, Hiroki
    Ikeda, Eriko
    Shiba, Takeshi
    Yamato, Mayumi
    Yamada, Ken-ichi
    Koyanagi, Satoru
    Ohdo, Shigehiro
    NEUROMOLECULAR MEDICINE, 2013, 15 (02) : 238 - 251
12345